Top compounds associated with response to EIF4H


Feature Type Standardized
Nominal ANOVA
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.012 0.7
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.013 0.7
mRNA AC220 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA 968 CTRPv2 pan-cancer AAC 0.026 0.7
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.013 0.7
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA cediranib CTRPv2 pan-cancer AAC -0.02 0.7
Download CSV